Stephen S. Yoder
2022
In 2022, Stephen S. Yoder earned a total compensation of $2.1M as Chief Executive Officer at Pieris Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $197,689 |
|---|---|
| Option Awards | $1,288,128 |
| Salary | $564,826 |
| Other | $12,200 |
| Total | $2,062,843 |
Yoder received $1.3M in option awards, accounting for 62% of the total pay in 2022.
Yoder also received $197.7K in non-equity incentive plan, $564.8K in salary and $12.2K in other compensation.
Rankings
In 2022, Stephen S. Yoder's compensation ranked 1,708th out of 5,694 executives tracked by ExecPay. In other words, Yoder earned more than 70.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,708 out of 5,694 | 70th |
Division Manufacturing | 890 out of 3,099 | 71st |
Major group Chemicals And Allied Products | 357 out of 1,406 | 75th |
Industry group Drugs | 326 out of 1,307 | 75th |
Industry Pharmaceutical Preparations | 232 out of 953 | 76th |
Source: SEC filing on November 6, 2024.
Yoder's colleagues
We found one more compensation record of an executive who worked with Stephen S. Yoder at Pieris Pharmaceuticals in 2022.
2022
Thomas Bures
Pieris Pharmaceuticals